Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-7 of 7

Sort by

Sort Order Select

Journal Articles

CD39 defines an exhausted effector memory T cell subset associated with poor outcome in Acute Myeloid Leukemia: Immunophenotypic and transcriptomic analysis

Yoon Seok Choi, Yoojeong Lee, Na Yeon Seong, Changgon Kim, Kunye Kwak, Cheongin Yang, Ka-Won Kang, Yong Park, Byung Soo Kim, Seong Hyun Jeong, Joon Seong Park

Blood (2025) 146 (Supplement 1): 1736.

https://doi.org/10.1182/blood-2025-1736

Published: 2025

Journal Articles

miRNA-mRNA analysis of mesenchymal stem cell derived extracellular vesicle mediated ex vivo expansion of hematopoietic stem cells

Kunye Kwak, Ji-Hea Kim, Dongjin Shin, Changgon Kim, Ka-Won Kang, Yoon Seok Choi, Byung Soo Kim, Yong Park

Blood (2025) 146 (Supplement 1): 1404.

https://doi.org/10.1182/blood-2025-1404

Published: 2025

Journal Articles

Real-world insights into ATRA-based maintenance therapy and prognostic markers of relapse in acute promyelocytic leukemia

Kunye Kwak, Changgon Kim, Yoon Seok Choi, Ka-Won Kang, Byung Soo Kim, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Byung-Hyun Lee, Se Ryeon Lee, Hwa Jung Sung, Mihee Kim, Seo-Yeon Ahn, Chang-Hoon Lee, Ho-Young Yhim, Jae-Sook Ahn, Yong Park

Blood (2025) 146 (Supplement 1): 1609.

https://doi.org/10.1182/blood-2025-1609

Published: 2025

Journal Articles

Effectiveness and safety of splenectomy or thrombopoietin receptor agonists as second-line treatments for patients with immune thrombocytopenia in a real-world setting

Hyung-Jun Lim, Kunye Kwak, Changgon Kim, Yoon Seok Choi, Yong Park, Byung Soo Kim, Ka-Won Kang

Blood (2025) 146 (Supplement 1): 4814.

https://doi.org/10.1182/blood-2025-4814

Published: 2025

Journal Articles

Long-Term Outcomes of Bronchus-Associated Lymphoid Tissue Lymphoma Based on Lung Involvement Status: A Single-Center Real-World Data Analysis in Korea

Changgon Kim, Seok Jin Kim, Won Seog Kim, SangEun Yoon

Blood (2024) 144 (Supplement 1): 6309.

https://doi.org/10.1182/blood-2024-206547

Published: 2024

Journal Articles

The Reason Why We Should Differentiate Monomorphic Epitheliotropic T Cell Lymphoma and Intestinal T Cell Lymphoma, NOS - a Retrospective Study about the Experience of a Single Tertiary Hospital in Korea

Jiyeon Hyeon, Changgon Kim, Sang Eun Yoon, Seok Jin Kim, Young Hyeh Ko, Junhun Cho, Won Seog Kim

Blood (2024) 144 (Supplement 1): 6419.

https://doi.org/10.1182/blood-2024-210911

Published: 2024

Journal Articles

Real-World Outcomes of Polatuzumab Vedotin with Bendamustine and Rituximab As Salvage and Bridge Therapy to CAR T-Cell Treatment in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Changgon Kim, SangEun Yoon, Hyun-Young Kim, Duck Cho, Hong Hoe Koo, Junhun Cho, Won Seog Kim, Seok Jin Kim

Blood (2024) 144 (Supplement 1): 3107.

https://doi.org/10.1182/blood-2024-204987

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

CD39 defines an exhausted effector memory T cell subset associated with poor outcome in Acute Myeloid Leukemia: Immunophenotypic and transcriptomic analysis

miRNA-mRNA analysis of mesenchymal stem cell derived extracellular vesicle mediated ex vivo expansion of hematopoietic stem cells

Real-world insights into ATRA-based maintenance therapy and prognostic markers of relapse in acute promyelocytic leukemia

Effectiveness and safety of splenectomy or thrombopoietin receptor agonists as second-line treatments for patients with immune thrombocytopenia in a real-world setting

Long-Term Outcomes of Bronchus-Associated Lymphoid Tissue Lymphoma Based on Lung Involvement Status: A Single-Center Real-World Data Analysis in Korea

The Reason Why We Should Differentiate Monomorphic Epitheliotropic T Cell Lymphoma and Intestinal T Cell Lymphoma, NOS - a Retrospective Study about the Experience of a Single Tertiary Hospital in Korea

Real-World Outcomes of Polatuzumab Vedotin with Bendamustine and Rituximab As Salvage and Bridge Therapy to CAR T-Cell Treatment in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

CD39 defines an exhausted effector memory T cell subset associated with poor outcome in Acute Myeloid Leukemia: Immunophenotypic and transcriptomic analysis

miRNA-mRNA analysis of mesenchymal stem cell derived extracellular vesicle mediated ex vivo expansion of hematopoietic stem cells

Real-world insights into ATRA-based maintenance therapy and prognostic markers of relapse in acute promyelocytic leukemia

Effectiveness and safety of splenectomy or thrombopoietin receptor agonists as second-line treatments for patients with immune thrombocytopenia in a real-world setting

Long-Term Outcomes of Bronchus-Associated Lymphoid Tissue Lymphoma Based on Lung Involvement Status: A Single-Center Real-World Data Analysis in Korea

The Reason Why We Should Differentiate Monomorphic Epitheliotropic T Cell Lymphoma and Intestinal T Cell Lymphoma, NOS - a Retrospective Study about the Experience of a Single Tertiary Hospital in Korea

Real-World Outcomes of Polatuzumab Vedotin with Bendamustine and Rituximab As Salvage and Bridge Therapy to CAR T-Cell Treatment in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only